Abstract
After introducing chirality with the winding columns of baroque altars and snail shells, the enantioselective hydrogenation of dehydroamino acids is described. Then, the enantioselective homo Diels-Alder reaction of norbornadiene with phenylacetylene is presented, which leads to 8-phenyldeltacyclene in almost enantiomerically pure form. Its reaction with 1,2-bisphosphanylbenzene affords P,P,P-tris(9-phenyldeltacyclan-8-yl)-1,2-bisphosphanylbenzene, a chelate ligand with 3 chiral deltacyclanyl substituents and a PH bond, comprising 24 asymmetric carbon atoms of a given configuration and a stereogenic secondary phosphorus atom. This chelate ligand forms mononuclear, phosphido-bridged dinuclear and - most unusual - trinuclear Ni, Pd and Pt complexes. The trinuclear complexes consisting of three joint square planar units are unique in Ni, Pd and Pt chemistry.
Keywords: pt phosphane complexes, chiral 9-phenyldeltacyclanyl substituent
Current Organic Chemistry
Title: Right or Left - Enantioselective Catalysis. New Ni, Pd and Pt Phosphane Complexes with the Chiral 9-Phenyldeltacyclanyl Substituent
Volume: 6 Issue: 5
Author(s): Henri Brunner
Affiliation:
Keywords: pt phosphane complexes, chiral 9-phenyldeltacyclanyl substituent
Abstract: After introducing chirality with the winding columns of baroque altars and snail shells, the enantioselective hydrogenation of dehydroamino acids is described. Then, the enantioselective homo Diels-Alder reaction of norbornadiene with phenylacetylene is presented, which leads to 8-phenyldeltacyclene in almost enantiomerically pure form. Its reaction with 1,2-bisphosphanylbenzene affords P,P,P-tris(9-phenyldeltacyclan-8-yl)-1,2-bisphosphanylbenzene, a chelate ligand with 3 chiral deltacyclanyl substituents and a PH bond, comprising 24 asymmetric carbon atoms of a given configuration and a stereogenic secondary phosphorus atom. This chelate ligand forms mononuclear, phosphido-bridged dinuclear and - most unusual - trinuclear Ni, Pd and Pt complexes. The trinuclear complexes consisting of three joint square planar units are unique in Ni, Pd and Pt chemistry.
Export Options
About this article
Cite this article as:
Brunner Henri, Right or Left - Enantioselective Catalysis. New Ni, Pd and Pt Phosphane Complexes with the Chiral 9-Phenyldeltacyclanyl Substituent, Current Organic Chemistry 2002; 6 (5) . https://dx.doi.org/10.2174/1385272024604943
DOI https://dx.doi.org/10.2174/1385272024604943 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Heme Oxygenase-1 as a Target for the Design of Gene and Pharmaceutical Therapies for Autoimmune Diseases
Current Gene Therapy HDL-C Levels and Cardiovascular Disease: More is not Always Better!
Recent Patents on Cardiovascular Drug Discovery Targeting Neurotrophin Receptors in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Reliability of Blood Pressure Patterns Defined by a Single 24-Hour Ambulatory Blood Pressure Monitoring: The Case of the Dipping/Non Dipping and Isolated Clinic Hypertension
Current Hypertension Reviews Targeting the NMDA Receptor for Fear-Related Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Metabolic Syndrome and Cardiometabolic Risk Factors
Current Vascular Pharmacology Non-Genomic Regulation of Cardiac Ion Channels by Sex Hormones
Cardiovascular & Hematological Disorders-Drug Targets Triglycerides and Cardiovascular Risk
Current Cardiology Reviews Why is the Inhibition of the Renin-Angiotensin System Effective for Preventing Cardiac Events in Patients with Coronary Risk Factors or Coronary Artery Disease?
Current Cardiology Reviews Editorial [Hot Topic: Naked Plasmid DNA for Gene Therapy (Guest Editors: Munehisa Shimamura & Ryuichi Morishita)]
Current Gene Therapy Cerebrovascular Ultrasonography for Selecting Patients for Stroke Intervention
Recent Patents on CNS Drug Discovery (Discontinued) Novel Approaches to Anti-atherosclerotic Therapy: Cell-based Models and Herbal Preparations (Review of Our Own Data)
Current Drug Discovery Technologies Future of Protease Activity Assays
Current Pharmaceutical Design Therapeutic Strategies in Parkinsons Disease
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery New Bidirectional Heavy Device for Launching Bridges Based on Inverted Caterpillar Mechanism
Recent Patents on Mechanical Engineering Efficacy of Zofenopril Alone or in Combination with Hydrochlorothiazide in Patients with Kidney Dysfunction
Current Clinical Pharmacology Crocin Protects Against Beta-Amyloid Peptide-Induced Apoptosis in PC12 Cells Via the PI3 K Pathway
Current Molecular Pharmacology Interactions between Ketamine and Magnesium for the Treatment of Pain: Current State of the Art
CNS & Neurological Disorders - Drug Targets Novel Oral Anticoagulation During Pulmonary Vein Isolation and Cardioversion
Cardiovascular & Hematological Disorders-Drug Targets Sestrins: A New Kid for Stroke Treatment?
Current Drug Delivery